Cargando…
Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana
Background: Cryptococcal antigen (CrAg) screening for antiretroviral therapy (ART)-naïve adults with advanced HIV/AIDS can reduce the incidence of cryptococcal meningitis (CM) and all-cause mortality. We modeled the cost-effectiveness of laboratory-based “reflex” CrAg screening for ART-naïve CrAg-po...
Autores principales: | Tenforde, Mark W., Muthoga, Charles, Callaghan, Andrew, Ponatshego, Ponego, Ngidi, Julia, Mine, Madisa, Jordan, Alexander, Chiller, Tom, Larson, Bruce A., Jarvis, Joseph N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871359/ https://www.ncbi.nlm.nih.gov/pubmed/31803848 http://dx.doi.org/10.12688/wellcomeopenres.15464.2 |
Ejemplares similares
-
Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2021) -
Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease
por: Jarvis, Joseph N., et al.
Publicado: (2020) -
Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs
por: Larson, Bruce, et al.
Publicado: (2022) -
Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
por: Tenforde, Mark W., et al.
Publicado: (2020) -
Immune correlates of HIV-associated cryptococcal meningitis
por: Tenforde, Mark W., et al.
Publicado: (2017)